We report the case of a two-week-old female neonate who presented to our outpatient clinic with a large neck hemangioma. The neonate was born to two phenotypically healthy parents and was delivered through normal labor on 38th week of an uneventful gestation. Perinatal history was reported to be normal with Apgar scores 8 at 1 minute and 9 at 5 minutes. There was no family history of hemangiomas.
On physical examination a soft violaceous mass with surface telangiectasias and peripheral pallor was located in the right supraclavicular region and was extending from the right clavicle to the middle of the right cervical lateral surface. The hemangioma was present at birth, but showed rapid growth within the two first weeks of life, attaining a size of 5,6cm x 4,4cm at the time of evaluation (Figure-1 ).
The neonate was hemodynamically stable with no signs and symptoms of heart failure. No murmur was audible, vital signs were within normal ranges for age (heart rate: 160/min with normal range 105-180/min, respiratory rate: J o u r n a l o f P e d i a t r i c S c i e n c e s 2016;8;e255 45/min with normal values <60/minute, blood pressure: 86/60mmHg-75th percentile, SpO2:8% with normal values ≥ 93%) and somatometric parameters were also within normal percentiles for gender and age (body weight: 2,61kg-75th percentile, body length: 53cm-90th percentile). Laboratory tests (complete blood count, biochemical and coagulation tests) had no pathologic findings. On the other hand, twelve-lead electrocardiography showed flattened ST segment at the lateral leads, while echocardiography revealed increased left ventricle size for age according to Detroit data about z-scores of cardiac structures, as well as decreased systolic function [2] . Left ventricle end-diastolic diameter was 26mm, z-score=3,76, left ventricular end-systolic diameter was 18mm, z-score=3,85 and left ventricle ejection fraction was 58%, normal values in childhood 64-83%. (Figure- 2) Brain and abdomen ultrasound revealed no further hemangiomas location.
We commenced per os heart failure therapy, which included digoxin (0,01mg/kg per day in 2 doses) and diuretics (furosemide: 1mg/kg per day in 2 doses and spironolactone: 1mg/kg per day in 2 doses) along with propranolol (2mg/kg per day in 2 doses). A month later left ventricle size and function had recovered and heart failure therapy progressively stopped. Therapy with propranolol continued for the treatment of the hemangioma. After 4 months of follow up the hemangioma had a size of 3,7cm x 3cm (33% and 35% regression respectively) and left ventricle size and function were within normal ranges (left ventricle end-diastolic diameter: 20mm, z-score=1,13, left ventricular end-systolic diameter: 11mm, z-score=-0,04 and ejection fraction: 80%).
Discussion
Infantile hemangiomas occur in 5-10% of infants consisting the most common childhood tumor. They are usually not present at birth and are noted within the first few weeks of life. There is typically an initial proliferative phase, with rapid tumor growth taking place in the first several months of life. This is followed by an involution phase, with slow, spontaneous resolution. A residual fibro fatty mass often persists [1] . Although they are istopathologically benign, they may be pathophysiologically malignant, as they can induce significant hemodynamic complications.
These complications can be due to either anatomical or functional impact. Marmade L, et al. presented the case of an atrial hemangioma which caused cardiac tamponade and was revealed as cardiogenic shock, but this case affected a young adult [3] . On the other hand, according to Shepherd, et al. during their rapid proliferative state (shortly after birth and during the first months of life) hemangiomas can behave as transiently high-flow arteriovenous malformations and create a high cardiac output state. This state leads to a circulatory overload and elevates diastolic pressure in the left ventricle, thus predisposing to pulmonary hypertension. With time this overload may evolve to systolic failure with reduced levels of cardiac output [4] . According to Blei, et al. hemangiomas with such a propensity to develop a high flow element are mainly those located in the liver, as well as in the head and neck (parotid, scalp, upper arm, upper lip) [5] . Indeed, Hsiao, et al. reported a neonate with a huge congenital hemangioma of the scalp presenting as high-output heart failure and KasabachMerritt syndrome [6] . Moreover, a case of a female neonate with a large congenital hemangioma on the neck causing heart failure and thrombocytopenia was described by Weitz, et al., while Sidwell, et al. reported a case of an infant with neonatal hemangiomatosis and secundum atrial septal defect who developed severe heart failure [7, 8] .
As regards treatment, an early surgical approach is usually avoided with the use of supportive treatment for heart failure (digoxin, diuretics) combined with propranolol. It was LeauteLabreze et al. in 2008 who first described the efficacy of β-blockers for the treatment of infantile hemangiomas and further studies subsequently documented the drug's efficacy and safety as a first-line, as well as second-line (after steroid use) therapy [9] . Different mechanisms have been proposed for this action of propranolol, including the promotion of pericyte-mediated vasoconstriction, the inhibition of vasculogenesis and catecholamineinduced angiogenesis and the disruption of hemodynamic force-induced cell survival [1] .
In our patient an infantile large neck hemangioma was associated with subclinical systolic dysfunction of the left ventricle, which was revealed in an echocardiography study and included dilatation of left ventricle and reduction of ejection fraction. Heart failure treatment with digoxin and diuretics (furosemide and spironolactone) was initiated along with propranolol and after 6 months of follow-up left ventricle had recovered and the hemangioma showed a marked regression.
However, it remains unclear whether it was the regression of the hemangioma itself or the heart failure therapy that mainly led to normalization of left ventricle function. A series of such cases could provide stronger evidence about the degree of association of left ventricle dysfunction with the size of the hemangioma.
According to Drolet, et al although routine electrocardiographic screening in children with hemangiomas has been advocated before initiation of treatment with propranolol, echocardiography is not necessary as a routine screening tool, because structural and functional heart disorders have not been associated with uncomplicated hemangiomas [10] . However, subtle subclinical heart dysfunction may be present in cases of infantile hemangiomas, even without apparent symptoms and the presence of cardiac dysfunction could consist an additional indication for early intervention along with disturbance of vital functions, lesions in centrofacial area and high risk for permanent deformity. On this basis, increased awareness about possible heart complications in infants with hemangiomas is needed and a thorough cardiac evaluation including echocardiography may be considered in cases of infants with giant hemangiomas. 
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